In Depth 10 Feb 2025 Monoclonal antibodies: are they the key to treating Alzheimer’s disease? …Monoclonal antibodies: approved for Alzheimer’s disease but not without concerns While remternetug’s progress is a major breakthrough, monoclonal antibodies have come a long way in addressing Alzheimer’s disease. The first… February 10, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 May 2024 Eight monoclonal antibody biotechs making strides in the clinic …(PIPE) deal. Monoclonal antibodies: an expanding therapeutic field The monoclonal antibodies market was valued at 210 billion in 2022, and is projected to increase by 11% every year until 2030…. May 2, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2017 One Mouse with All-Human Antibodies …be used to produce antibodies for human therapeutic use. Murine monoclonal antibodies were used until the late 1900s. Soon, however, it became apparent that the disadvantages outweighed their positive characteristics:… November 29, 2017 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 18 Sep 2024 Two targets, one solution: The rise of bispecific antibodies …Table of contents What are bispecific antibodies? Bispecific antibodies are basically next-generation monoclonal antibodies (mAbs). But whereas mAbs target just one epitope (a part of an antigen that interacts with… September 18, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Interview 19 Aug 2022 How re-engineering antibodies can prevent allergies …Derek Croote (DC): IgGenix takes a novel approach by re-engineering IgE monoclonal antibodies (mAbs) to block and even prevent allergic reactions. These IgE antibodies cause allergic reactions when they recognize… August 19, 2022 - 9 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
In Depth 13 Jun 2023 Abeta-targeting antibodies pave the way for Alzheimer’s disease vaccines …tolerated than monoclonal antibodies. • In addition, some monoclonal antibody side effects have been associated with peaks and troughs in the concentration of monoclonal antibodies, which occur around injections. •… June 13, 2023 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 13 Jun 2025 A new era in migraine treatment: Innovative drugs redefining the field …oral administration. Monoclonal antibodies targeting CGRP: A game changer in migraine treatment Hailed as being even more revolutionary than gepants, however, is the development of monoclonal antibodies that target CGRP…. June 13, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jun 2022 Scancell to produce and clinically validate T cell redirecting bispecific antibodies …antibodies To create TCB antibodies, Scancell will combine its GlyMab antibodies, which target sugar motifs rather than proteins and are designed to have superior affinity and selectivity profiles, with in-licenced… June 23, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 28 May 2025 Myasthenia gravis treatments: what’s on the horizon? …in patients with myasthenia gravis. FcRn blockers are medicines that block the Fc receptor. In myasthenia gravis, autoantibodies – antibodies that mistakenly target the body’s own cells and proteins –… May 28, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 Apr 2019 The 8 Best Biotech Companies in Europe’s History …antibodies are made today. “There wasn’t much interest in antibodies in the early 90s,” Winter told us, “but we had the idea of developing some completely novel technology where we… April 2, 2019 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 1 Nov 2016 This Technology could Open Up a new 4th Generation of Therapeutic Antibodies From everyday immunostaining to billion-euro therapies, antibodies have become essential in Biotech. Selecting the right antibodies that are as close to human as possible minimizes risks and can be the… November 1, 2016 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 10 Feb 2017 Can Biotech make Antivenoms Better and Cheaper with Antibodies? …be the ideal solution. To target all the common toxins involved, there’s a need for a mixture of antibodies. Different methods considered for the production of antibodies. Mixtures of antibodies… February 10, 2017 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email